Resverlogix needs to speed things up with apabetalone, a potential therapeutic for COVID 19 infection. (Koo)

"...we could have this data as early as May." (Don on February 4, 2021)

28 day trial. Three months plus to wait for the results.

Remember all of the chatter from about a year or so ago, when we were all hoping that the new guidelines from the FDA would be a door opener for Resverlogix? Maybe Covid-19 cracks (demolishes?) that door open for us, and they take a long sober look at what they can do for us! We missed by a whisker in BetonMace - so maybe they can tweak something!